Document Detail


Mesangial medium with IgA1 from IgA nephropathy inhibits nephrin expression in mouse podocytes.
MedLine Citation:
PMID:  19397686     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: IgA nephropathy (IgAN) is characterized by mesangial deposition of polymeric IgA1, and podocyte injury plays an important role in glomerulosclerosis of the disease. Our previous study indicated that medium of mesangial cells co-incubated with aggregated IgA1 (aIgA1), isolated from IgAN patients, down-regulated nephrin expression. Yet the mechanism remains unclear. MATERIALS AND METHODS: Podocytes were incubated with a medium of mesangial cells co-incubated with aIgA1, which was isolated from IgAN patients, and enalaprilat (10(-5) M), valsartan (10(-5) M) and anti-mouse tumour necrosis factor-alpha antibody (50 ng mL(-1)) separately. Nephrin expression in podocytes was measured by real-time polymerase chain reaction and Western blot analysis. RESULTS: The level of angiotensinogen and angiotensin-converting enzyme mRNAs in podocytes, as well as angiotensin, was also increased by a medium of mesangial cells co-incubated with aIgA1 from IgAN patients (P<0.05). Enalaprilat or valsartan partly improved nephrin expression when compared with that by podocytes exposed to the mesangial medium (P<0.05), while the nephrin expression of podocytes with enalaprilat or valsartan was lower than that of podocytes exposed to medium of mesangial cells stimulated by aIgA1 from healthy control (P<0.05). However, anti-mouse tumour necrosis factor-alpha antibody did not show any improvement in nephrin expression. CONCLUSION: Our findings implicate that local renin angiotensin system activation in podocytes is partly involved in down-regulation of nephrin by mesangial medium in IgA nephropathy.
Authors:
C Wang; X Liu; Z Ye; J Zhang; H Tang; Z Chen; H Zhang; T Lou
Related Documents :
15153756 - Changes of rat kidney aqp2 and na,k-atpase mrna expression in lithium-induced nephrogen...
12519776 - Mouse retinal dehydrogenase 4 (raldh4), molecular cloning, cellular expression, and act...
11181406 - Genetic deletion of cox-2 prevents increased renin expression in response to ace inhibi...
17460566 - Influence of angiotensin ii on expression of toll-like receptor 2 and maturation of den...
2064726 - Dna methylation and oncogene expression in methapyrilene-induced rat liver tumors and i...
24465846 - Microarray analysis of rat pancreas reveals altered expression of alox15 and regenerati...
Publication Detail:
Type:  Journal Article     Date:  2009-04-24
Journal Detail:
Title:  European journal of clinical investigation     Volume:  39     ISSN:  1365-2362     ISO Abbreviation:  Eur. J. Clin. Invest.     Publication Date:  2009 Jul 
Date Detail:
Created Date:  2009-06-23     Completed Date:  2010-02-22     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0245331     Medline TA:  Eur J Clin Invest     Country:  England    
Other Details:
Languages:  eng     Pagination:  561-7     Citation Subset:  IM    
Affiliation:
Department of nephrology,The 3rd affiliated hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Cells, Cultured / metabolism
Down-Regulation / drug effects
Gene Expression / drug effects
Glomerulonephritis, IGA / genetics,  pathology*
Humans
Immunoglobulin A / genetics,  metabolism*
Membrane Proteins / drug effects,  metabolism*
Mesangial Cells / metabolism*
Mice
Podocytes / metabolism*
Reference Values
Renin-Angiotensin System / drug effects*,  genetics
Chemical
Reg. No./Substance:
0/Immunoglobulin A; 0/Membrane Proteins; 0/nephrin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Triggering of suicidal erythrocyte death by radiocontrast agents.
Next Document:  Effect of polymerized-type I collagen in knee osteoarthritis. II. In vivo study.